Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Tislelizumab 200 / Paclitaxel 175 / Carboplatin 5, Non-Small Cell Lung Cancer

Protocol-ID: 2647 V1.0 (Mini), TISL200/PACL175/CRBP5, NSCLC

Indication(s)

  • Lung Carcinoma, Non-Small Cell (Squamous Cell Carcinoma); ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 14.06.2024